made quick, painless and accessible for all women!
Mihir Shah
Bhaumik Sanghvi
Matthew Campisi
Founder
Mihir Shah, Matthew Campisi, Bhaumik Sanghvi
Company iBreastExam
Certifications US FDA, CE, ISO, CDSCO
Website https://www.uelifesciences.com/
Partnered with AMF 2016
Sector Breast cancer screening
Headquarters Philadelphia, USA
Founded 2009
1 woman is diagnosed with breast cancer every 4 minutes in India
Breast cancer is the most common cancer among women. Although breast cancer is curable if diagnosed early, India recorded 98,000 deaths due to breast cancer in 2022- the reason is lack of access to screening. Mammography equipment is present only in key cities, requires a radiologist, is costly, is a painful experience for most women, involves radiation and is not accurate for women under 40 with dense breasts.
iBreastExam is a pain-free and ultra-portable solution
iBreastExam is a hand-held, ultra- portable, pain-free, radiation free, breast cancer screening device that allows early screening of lumps in the breast with instant results. The device measures tissue elasticity non-invasively through the principle of dynamic co-planar capacitive sensors and is FDA approved. iBreastExam scan costs 1/10th the cost of a mammography and can be easily operated by a frontline healthcare worker.
Impact
1
Scans issued
1
Countries
Scale
Partnership with multiple state governments to scan lakhs of women in the states of Goa, UP, Gujarat, Maharashtra and Chhattisgarh and multiple NGOs
Government and NGO Partnerships
Partnered with major pharma companies, deployed in renowned hospitals across India as well as with major corporate firms.
Commercial Collaborations
